Literature DB >> 15951024

Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity.

Florian Kaestner1, Michael Hettich, Marion Peters, Walter Sibrowski, Günter Hetzel, Gerald Ponath, Volker Arolt, Uwe Cassens, Matthias Rothermundt.   

Abstract

BACKGROUND: Recent studies showed an activation of the cytokine system and the HPA axis in major depression, although with inconsistent results. While the non-melancholic subtype displayed a proinflammatory cytokine pattern, the melancholic subtype showed signs of impaired cytokine production. In order to understand the potential pathogenic significance of these systems further, the interplay between the cytokine system and the HPA axis in depressive subtypes as well as potential changes of these systems during the course of disease were investigated.
METHODS: N=37 initially unmedicated patients with acute major depression were sub-classified (melancholic vs. non-melancholic) and compared with N=37 matched healthy controls. Upon admission and after complete clinical remission, basal plasma ACTH and serum cortisol levels as well as cytokine productions (IL-1beta, IL-1 receptor antagonist (IL-1RA)) upon mitogen stimulation (PHA) were measured in a whole blood assay.
RESULTS: ACTH and cortisol concentrations were significantly elevated on admission in the melancholic but not the non-melancholic subgroup. Non-melancholic patients produced significantly more IL-1beta and IL-1RA upon admission than controls or melancholic patients. The IL-1 RA/IL-1beta ratio was significantly lower in the non-melancholic compared to the melancholic subgroup and increased significantly upon remission. LIMITATIONS: Patient treatment was not standardized. No Dex/CRH test was performed.
CONCLUSIONS: Melancholic patients demonstrated an activation of the HPA axis in acute stage with partial normalization upon remission but no signs of inflammation. Non-melancholic patients showed signs of inflammation in acute depression with normalization upon remission while the function of the HPA axis was normal.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951024     DOI: 10.1016/j.jad.2005.03.012

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  47 in total

1.  A preliminary study of the effects of repeated massage on hypothalamic-pituitary-adrenal and immune function in healthy individuals: a study of mechanisms of action and dosage.

Authors:  Mark H Rapaport; Pamela Schettler; Catherine Bresee
Journal:  J Altern Complement Med       Date:  2012-07-09       Impact factor: 2.579

Review 2.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble.

Authors:  Eléonore Beurel; Marisa Toups; Charles B Nemeroff
Journal:  Neuron       Date:  2020-06-17       Impact factor: 17.173

3.  Anhedonia as a clinical correlate of inflammation in adolescents across psychiatric conditions.

Authors:  Rachel D Freed; Lushna M Mehra; Daniel Laor; Manishkumar Patel; Carmen M Alonso; Seunghee Kim-Schulze; Vilma Gabbay
Journal:  World J Biol Psychiatry       Date:  2018-08-16       Impact factor: 4.132

4.  Inflammatory biomarkers in depression: an opportunity for novel therapeutic interventions.

Authors:  Madeline Li; Joanna K Soczynska; Sidney H Kennedy
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

5.  Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.

Authors:  Gavin Rush; Aoife O'Donovan; Laura Nagle; Catherine Conway; AnnMaria McCrohan; Cliona O'Farrelly; James V Lucey; Kevin M Malone
Journal:  J Affect Disord       Date:  2016-06-17       Impact factor: 4.839

6.  Molecular serum signature of treatment resistant depression.

Authors:  Tillmann Ruland; Man K Chan; Pawel Stocki; Laura Grosse; Matthias Rothermundt; Jason D Cooper; Volker Arolt; Sabine Bahn
Journal:  Psychopharmacology (Berl)       Date:  2016-06-20       Impact factor: 4.530

Review 7.  Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics.

Authors:  Andrea H Marques; Marni N Silverman; Esther M Sternberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

8.  Association between major depression and cardiovascular risk: the role of antidepressant medication.

Authors:  Linn K Kuehl; Christoph Muhtz; Kim Hinkelmann; Lucia Dettenborn; Katja Wingenfeld; Carsten Spitzer; Christian Otte
Journal:  Psychopharmacology (Berl)       Date:  2016-07-27       Impact factor: 4.530

Review 9.  Blood-based biomarkers predicting response to antidepressants.

Authors:  Yasmin Busch; Andreas Menke
Journal:  J Neural Transm (Vienna)       Date:  2018-01-27       Impact factor: 3.575

Review 10.  Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.

Authors:  Stefan M Gold; Michael R Irwin
Journal:  Immunol Allergy Clin North Am       Date:  2009-05       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.